Search Orphan Drug Designations and Approvals
-
Generic Name: | 4-fluoro-5-((6-methylhexahydropyrrolo[3,4-b] pyrrol-5(1H)-yl) sulfonyl) isoquinoline |
---|---|
Date Designated: | 02/05/2020 |
Orphan Designation: | Treatment of idiopathic pulmonary fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
The National Institutes of Pharmaceutical R&D Co., Ltd No. 27, Zhansimen Road Shahe, Changping District Beijing China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-